A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

PHASE2TerminatedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

November 16, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Psoriasis
Interventions
DRUG

Cedirogant

Capsule, Oral

DRUG

Placebo

Capsule, Oral

Trial Locations (53)

11415

Forest Hills Dermatology Group /ID# 238708, Kew Gardens

14221

Buffalo Medical Group /ID# 239068, Williamsville

15260

University of Pittsburgh MC /ID# 246170, Pittsburgh

28277

Darst Dermatology /ID# 238677, Charlotte

28403

Wilmington Dermatology Center /ID# 246445, Wilmington

29407

Clinical Research Center of the Carolinas /ID# 238827, Charleston

33014

Lakes Research, LLC /ID# 238831, Miami

33172

Lenus Research & Medical Group /ID# 238695, Sweetwater

33173

Florida International Rsrch cr /ID# 245959, Miami

33607

Clinical Research Trials of Florida, Inc. /ID# 238709, Tampa

35233

UAB Department of Dermatology /ID# 238563, Birmingham

44106

Univ Hosp Cleveland /ID# 245953, Cleveland

46256

Dawes Fretzin, LLC /ID# 238704, Indianapolis

57702

Health Concepts /ID# 238510, Rapid City

60008

Arlington Dermatology /ID# 238701, Rolling Meadows

68144

Skin Specialists, PC /ID# 238514, Omaha

72117

Arkansas Research Trials, LLC /ID# 238687, North Little Rock

76011

Arlington Research Center, Inc /ID# 244171, Arlington

77401

Bellaire Dermatology Associates /ID# 247865, Bellaire

78229

Progressive Clinical Research /ID# 238565, San Antonio

91436

Encino Research Center /ID# 245950, Encino

91606

Velocity Clinical Research, Inc. /ID# 239536, North Hollywood

92103

Medderm Associates /ID# 238834, San Diego

97210

Oregon Dermatology and Research Center /ID# 238823, Portland

99202

Dermatology Specialists of Spokane /ID# 238809, Spokane

85006-2722

Medical Dermatology Specialist /ID# 238518, Phoenix

33607-6429

Advanced Clinical Research Institute /ID# 238697, Tampa

33613-1244

ForCare Clinical Research /ID# 238856, Tampa

30534-6369

Cleaver Medical Group Dermatology - Dawsonville /ID# 246327, Dawsonville

30060-1047

Marietta Dermatology Clinical Research /ID# 238679, Marietta

55424-1200

Zel Skin & Laser Specialists - Edina /ID# 238714, Edina

45040-4520

Dermatologists of Southwest Ohio, Inc /ID# 238939, Mason

02919

Clinical Partners, LLC /ID# 238620, Johnston

37215-2885

Tennessee Clinical Research Center /ID# 238682, Nashville

78759-4100

Orion Clinical Research /ID# 238619, Austin

77004-8097

Center for Clinical Studies - Houston (Binz) /ID# 243700, Houston

26505-0589

West Virginia Research /ID# 238517, Morgantown

V3R 6A7

Dr. Chih-ho Hong Medical Inc. /ID# 238864, Surrey

R3M 3Z4

Wiseman Dermatology Research /ID# 238867, Winnipeg

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center /ID# 238861, Barrie

N6H 5L5

Dr. Wei Jing Loo Medicine Prof /ID# 238865, London

L3P 1X2

Lynderm Research Inc. /ID# 243199, Markham

N2J 1C4

K. Papp Clinical Research /ID# 239695, Waterloo

467-8602

Nagoya City University Hospital /ID# 239286, Nagoya

080-0013

Takagi Dermatology Clinic /ID# 239274, Obihiro-shi

060-0033

JR Sapporo Hospital /ID# 239277, Sapporo

514-8507

Mie University Hospital /ID# 239275, Tsu

700-8558

Okayama University Hospital /ID# 239285, Okayama

573-1191

Kansai Medical University Hospital /ID# 239278, Hirakata-shi

431-3192

Hamamatsu University Hospital /ID# 239346, Hamamatsu

105-8471

The Jikei University Hospital /ID# 239319, Minato-ku

141-8625

NTT Medical Center Tokyo /ID# 239287, Shinagawa-ku

160-0023

Tokyo Medical University Hospital /ID# 239320, Shinjuku-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY